For the independent thinker.
Protection saves lives
The notion that society should drop patent protection for medicines has been debunked by the London School of Pharmacy.
In a major study of what might happen if innovations are not ringfenced from copyists, the authors claim unprotected medicines will herald the death of R&D as we know it, and those who currently invest in R&D will simply walk away.
The report authors, led by maverick Professor David Taylor, also dismiss the argument that because poor countries can’t afford to pay for the R&D ticket, patent protection should be kicked into touch globally.
They cite differential pricing as one solution to the problem, while accepting the difficulties of implementation and policing distribution this would cause.
Clearly this is not just a poor country problem, but a global problem, requiring a global solution.
Patent protection saves lives.
To read the latest issue of PharmaTimes Magazine, sign up for a free digital subscription or download our free app via iTunes or Google play.
About PharmaTimes Magazine
PharmaTimes Magazine is the ONLY UK publication designed for all levels
of industry management – offering original, news-driven features on all
aspects of the sector, from sales and marketing to clinical, regulatory,
advertising, PR and human resources. A comprehensive round up of global
industry and National Health Service news, as well the latest
developments in the agency and recruitment arenas, will also help you
stay ahead of the pack.
Average circulation Jan - Dec 2013: 23,178
PharmaTimes Online News Archive offers unique access to past issues of PharmaTimes Magazine and news elert stories.
©PharmaTimes Magazine 2014. All rights reserved. Material prepared by PharmaTimes Magazine is prohibited for use by third parties and publishers without permission.